Our Faculty
Gregory Pontone, M.D., M.H.S.
Publications of Gregory Pontone, M.D., M.H.S.
Psychotropic-Induced Movement Disorders and Cognitive Side Effects (Update)
1.25 CMEs
A review of drug-induced movement disorders and cognitive side effects from psychotropic medications. The presentation covers diagnostic criteria, management strategies, and evidence-based treatments for akathisia, extrapyramidal symptoms, tardive dyskinesia, and medication-induced tremors.
Quick Take Vol. 59
0.50 CMEs
In this Quick Take volume, our expert faculty investigate the link between insomnia symptoms and stroke risk, analyze the long-term effectiveness of antipsychotics in treating schizophrenia, and examine the safety of oral antipsychotics for older adults after surgery. Our experts also assess the benefits and risks of medical cannabis in Parkinson's disease treatment and explore neuroradiological abnormalities in first-episode psychosis.
Quick Take Vol. 55
0.75 CMEs
In this Quick Take volume, our expert faculty examine research on tobacco use and nicotine dependence among adults with psychosis, the risk of irreversible sexual dysfunction associated with SSRIs, and the effects of dual orexin receptor antagonists on delirium prevention. Our faculty also discuss sleep disorders in Parkinson’s disease and the pharmacologic treatment of obsessive-compulsive disorder.
Quick Take Vol. 53
0.50 CMEs
In this Quick Take volume, our expert faculty examine research on the effects of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression; aripiprazole co-prescription on prolactin levels among hospitalized patients; and the use of colony-stimulating factor on the outcomes of patients undergoing clozapine rechallenge. Selected faculty experts also discuss the phenomenon of tardive syndromes and appropriate management for these as well as the effect of pharmacogenomic testing on the outcomes of major depressive disorder.
Drug-Induced Movement Disorders: The Clinical Essentials – Interview
0.50 CMEs
In this interview, Dr. Gregory Pontone reviews the 4 different drug-induced movement disorders. He describes their phenomenology and available treatments, like beta-blockers, benzodiazepines, anticholinergics, and VMAT2 inhibitors. He also shares practical tips for initiating these treatments and their length.
Pharmacotherapy of Psychiatric Syndromes in Parkinson’s Disease – Interview
0.50 CMEs
In this interview, Dr. Gregory Pontone discusses how to best manage psychiatric symptoms in Parkinson’s disease patients. This includes the interface between depression, anxiety, and Parkinson’s disease; atypical Parkinson’s syndromes; dementia; psychotic symptoms; and sleep issues.
Drug-Induced Movement Disorders: The Clinical Essentials
1.25 CMEs
In this presentation, Dr. Gregory Pontone discusses drug-induced movement disorders, including akathisia, EPS, tardive dyskinesia, and acute dystonia. He also guides clinicians on how to differentiate them from Parkinson's disease tremors. Likewise, Dr. Pontone reviews medications associated with movement disorders and treatment strategies that are useful in these cases.
Pharmacotherapy of Psychiatric Syndromes in Parkinson’s Disease
1.00 CMEs
In this presentation, Dr. Greg Pontone teaches how to identify and manage common psychiatric manifestations of Parkinson's disease, including depression, anxiety, psychosis, and impulse-control disorders.